NasdaqCM - Nasdaq Real Time Price USD

Bio-Path Holdings, Inc. (BPTH)

2.6850 -0.2350 (-8.05%)
At close: April 23 at 4:00 PM EDT
2.6500 -0.03 (-1.30%)
After hours: April 23 at 7:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Operating Income
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Net Non Operating Interest Income Expense
36.0000
36.0000
33.0000
3.0000
26.0000
Other Income Expense
-271.0000
-271.0000
--
--
--
Pretax Income
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Net Income Common Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Diluted NI Available to Com Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Basic EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Diluted EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Basic Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Diluted Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Total Operating Income as Reported
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Total Expenses
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Net Income from Continuing & Discontinued Operation
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Normalized Income
-15,807.0000
-15,807.0000
-13,868.0000
-10,440.0000
-10,882.0000
Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
Net Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
EBIT
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
EBITDA
-15,665.0000
-15,665.0000
-13,723.0000
-10,282.0000
-10,757.0000
Reconciled Depreciation
178.0000
178.0000
178.0000
161.0000
151.0000
Net Income from Continuing Operation Net Minority Interest
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Total Unusual Items Excluding Goodwill
-271.0000
-271.0000
--
--
--
Total Unusual Items
-271.0000
-271.0000
--
--
--
Normalized EBITDA
-15,394.0000
-15,394.0000
-13,723.0000
-10,282.0000
-10,757.0000
12/31/2020 - 3/4/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MLEC Moolec Science SA
1.7300
-29.96%
 
PALI Palisade Bio, Inc.
5.92
+20.08%
 
LGVN Longeveron Inc.
1.8200
-2.67%
 
VNDA Vanda Pharmaceuticals Inc.
4.6300
-3.54%
 
NKGN NKGen Biotech, Inc.
1.8500
+25.85%
 
JAGX Jaguar Health, Inc.
0.1680
-6.61%
 
BNTC Benitec Biopharma Inc.
6.86
+2.08%
 
BRTX BioRestorative Therapies, Inc.
1.3400
-2.19%
 
CLNN Clene Inc.
0.3351
+0.63%
 
SNGX Soligenix, Inc.
0.4000
-1.43%